Stockyoda,Possible.. but maybe just Soverign risk ON/off, with Mali sanctions and Congo ML uncertainty.Back to Core, AGM about 7 weeks ago stated LiOH scoping study by H2 2022. So say report lands on desk Xmas, some light reading over Xmas/new year, early January prepare Board papers. Previous announcements 'Board approved' mid month, so say January Board meeting nowish, then maybe Big announcement very soon, say next week.By big announcement my thinking, LiOH is a go, good feedstock from 4000 assay results, fully funded from Stage 1 profits.. still early days need PFS, DFS, FID, etc, but good news. Could fund managers also be sensing?
Banter and general comments, page-6827
Add CXO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
-0.002(2.13%) |
Mkt cap ! $196.5M | |||
| Open | High | Low | Value | Volume |
| 9.4¢ | 9.4¢ | 9.0¢ | $1.679M | 18.34M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 293 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.3¢ | 276590 | 6 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
9.2¢ |
Change
-0.002 ( 2.23 %) |
||||
| Open | High | Low | Volume | ||
| 9.4¢ | 9.4¢ | 9.0¢ | 10903918 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| CXO (ASX) Chart |